Media Newsroom of

Lacerta Therapeutics

Follow on Social Network
14189 NW 129th Way
Alachua, FL 32615
Lacerta Therapeutics

Lacerta Therapeutics is a clinical-stage gene therapy company leveraging its proprietary adeno-associated virus (AAV) vector technology and manufacturing platforms to develop treatments for central nervous system and lysosomal storage diseases.

Lacerta Therapeutics Signs Gene Therapy Research Partnership with UCB

Lacerta Therapeutics Signs Gene Therapy Research Partnership with UCB

Lacerta Therapeutics today announced a new gene therapy research collaboration with UCB, a global biopharmaceutical company. The research collaboration and licensing agreement with UCB will focus on a central nervous system (CNS) disease with a high unmet need. “At Lacerta,…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login